/NAOV
NAOV Stock - NanoVibronix, Inc.
Healthcare|Medical - DevicesNASDAQ
$4.02-6.73%
$0.29 (-6.73%) • Dec 11
42
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.38
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $4.42
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for NAOV
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$3.98 – $4.06
TARGET (TP)$4.62
STOP LOSS$3.70
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.06
52W High$162.50
52W Low$2.93
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.56M | $2.28M | $752,000 | $1.70M | $623,000 |
| Gross Profit | $1.51M | $1.54M | $167,000 | $770,000 | $214,000 |
| Gross Margin | 59.0% | 67.3% | 22.2% | 45.4% | 34.3% |
| Operating Income | $-3,582,000 | $-3,436,000 | $-5,012,000 | $-5,683,000 | $-4,719,000 |
| Net Income | $-3,705,000 | $-3,711,000 | $-5,448,000 | $-14,282,000 | $-4,326,000 |
| Net Margin | -144.8% | -162.5% | -724.5% | -842.6% | -694.4% |
| EPS | $-13.73 | $-21.20 | $-38.40 | $-113.50 | $-84.00 |
Company Overview
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
NAOVBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.91
Q4 2025
EPS Surprise History
Q2 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 18, 2026 | — | — | — | — |
Q4 2025 | Nov 14, 2025 | — | $-0.91 | — | — |
Q3 2025 | Aug 19, 2025 | — | $-1.03 | — | — |
Q2 2025 | May 20, 2025 | — | $-39.80 | — | — |
Q1 2025 | Mar 31, 2025 | — | $-4.51 | — | — |
Q4 2024 | Nov 14, 2024 | — | $-39.60 | — | — |
Q3 2024 | Aug 14, 2024 | — | $-27.50 | — | — |
Q2 2024 | May 15, 2024 | — | $-25.30 | — | — |
Q2 2024 | Apr 8, 2024 | — | $-42.90 | — | — |
Q4 2023 | Nov 13, 2023 | — | $-46.20 | — | — |
Q3 2023 | Aug 11, 2023 | — | $-71.51 | — | — |
Q2 2023 | May 15, 2023 | — | $-73.71 | — | — |
Q2 2023 | Apr 17, 2023 | — | $-14.50 | — | — |
Q4 2022 | Nov 14, 2022 | — | $-66.01 | — | — |
Q3 2022 | Aug 15, 2022 | — | $-110.01 | — | — |
Q2 2022 | May 17, 2022 | — | $-8.09 | — | — |
Q2 2022 | Apr 5, 2022 | — | $-18.96 | — | — |
Q4 2021 | Nov 16, 2021 | — | $-198.02 | — | — |
Q3 2021 | Aug 16, 2021 | — | $-88.01 | — | — |
Q2 2021 | May 24, 2021 | — | $-40.69 | — | — |
Latest News
NanoVibronix Mulls Strategic Initiatives For Its NanoVibronix Technologies, CEO Tells Shareholders
➖ NeutralBenzinga•Nov 19, 2025, 01:02 PM
NanoVibronix Announces $2M Registered Direct Offering Of 291,204 Shares At $7.01/Share
➖ NeutralBenzinga•Sep 16, 2025, 07:58 PM
NanoVibronix shares are trading higher after its subsidiary, ENvue Medical, was granted a U.S. patent titled "Insertion Device Positioning Guidance System and Method."
📈 PositiveBenzinga•Sep 15, 2025, 12:05 PM
NanoVibronix Subsidiary, ENvue Medical, Granted US Patent Titled 'Insertion Device Positioning Guidance System and Method'
📈 PositiveBenzinga•Sep 15, 2025, 12:05 PM
Nanovibronix Announces That Its Wholly-owned Subsidiary, Envue Medical Holdings Has Been Granted A U.S. Patent For The Company's Proprietary Method For Overlaying Electromagnetic Navigation Data Onto Real-time Medical Imaging
📈 PositiveBenzinga•Sep 4, 2025, 12:12 PM
NanoVibronix announces pricing of $10 million public offering
➖ NeutralSeeking Alpha•May 15, 2025, 01:32 PM
Frequently Asked Questions about NAOV
What is NAOV's current stock price?
NanoVibronix, Inc. (NAOV) is currently trading at $4.02 per share. The stock has moved -6.73% today.
What is the analyst price target for NAOV?
No analyst price targets are currently available for this stock.
What sector is NanoVibronix, Inc. in?
NanoVibronix, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is NAOV's market cap?
NanoVibronix, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does NAOV pay dividends?
No, NanoVibronix, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACON
Aclarion, Inc.
$6.20
Mkt Cap: $0.0B
AMIX
Autonomix Medical, Inc. Common Stock
$0.63
Mkt Cap: $0.0B
BBLG
Bone Biologics Corporation
$1.83
Mkt Cap: $0.0B
BJDX
Bluejay Diagnostics, Inc.
$0.80
Mkt Cap: $0.0B
CNSP
CNS Pharmaceuticals, Inc.
$6.51
Mkt Cap: $0.0B
GRI
GRI Bio, Inc.
$0.34
Mkt Cap: $0.0B
HSCS
HeartSciences Inc.
$2.36
Mkt Cap: $0.0B
MOVE
Movano Inc.
$8.39
Mkt Cap: $0.0B
NDRA
ENDRA Life Sciences Inc.
$5.16
Mkt Cap: $0.0B
VERO
Venus Concept Inc.
$1.92
Mkt Cap: $0.0B
Explore stocks similar to NAOV for comparison